• No results found

Stent restenosis

Original Article A real world analysis of the angiographic patterns of in-stent restenosis and clinical outcome of second drug-eluting stent implantation

Original Article A real world analysis of the angiographic patterns of in-stent restenosis and clinical outcome of second drug-eluting stent implantation

... erolimus-eluting stent, seven patients received Excel sirolimus-eluting stents and six patients received Taxus paclitaxel-eluting ...in-stent restenosis pattern following primary stent ...

6

Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort study

Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort study

... A standard case report form (CRF) was used to col- lect patients’ demographic and clinical characteristics, including age, gender, smoking, drinking, CAD risk fac- tors, family history, life style, medical history and ...

9

Original Article The expression and role of LC3II and inflammatory cytokines in in-stent restenosis after percutaneous coronary intervention in patients with coronary heart disease

Original Article The expression and role of LC3II and inflammatory cytokines in in-stent restenosis after percutaneous coronary intervention in patients with coronary heart disease

... in-stent restenosis after percutaneous coronary intervention (PCI) in patients with coronary heart disease ...in-stent restenosis in the obser- vation group and an additional 64 CHD patients ...

6

Impacts of CYP2C19 Polymorphism and Clopidogrel Dosing on in-Stent Restenosis: A Retrospective Cohort Study in Chinese Patients

<p>Impacts of <em>CYP2C19</em> Polymorphism and Clopidogrel Dosing on in-Stent Restenosis: A Retrospective Cohort Study in Chinese Patients</p>

... In patients undergoing percutaneous coronary intervention (PCI), ischemic events often occur, as a result of in-stent restenosis (ISR), with the incidence of 5%-15%, despite the dual antiplatelet therapy ...

8

A better effect of cilostazol for reducing in-stent restenosis after femoropopliteal artery stent placement in comparison with ticlopidine

A better effect of cilostazol for reducing in-stent restenosis after femoropopliteal artery stent placement in comparison with ticlopidine

... after stent implantation associated with the use of ...cumulative stent length were relatively imbalanced between the cilostazol group and the ticlopidine ...cumulative stent length, and demonstrated ...

7

Visit-to-visit HbA1c variability is associated with in-stent restenosis in patients with type 2 diabetes after percutaneous coronary intervention

Visit-to-visit HbA1c variability is associated with in-stent restenosis in patients with type 2 diabetes after percutaneous coronary intervention

... in-stent restenosis (ISR) [5, ...although restenosis rate has significantly declined, diabetic patients still suffer from higher risk of ISR than non-diabetic patients [7, ...

12

A Mechanobiological Framework for the Prediction of In Stent Restenosis; Insights into the role of load induced damage in restenotic growth

A Mechanobiological Framework for the Prediction of In Stent Restenosis; Insights into the role of load induced damage in restenotic growth

... in-stent restenosis. Whilst stent induced vascular injury has been extensively identified as the predominant stimulus for subsequent synthetic VSMC proliferation and restenotic neo-intimal growth ...

6

An Investigation of Damage Mechanisms in Mechanobiological Models of In Stent Restenosis

An Investigation of Damage Mechanisms in Mechanobiological Models of In Stent Restenosis

... improve stent designs and minimise in-stent restenosis, it is critical to obtain a thorough understanding of the mechanobiology of arterial tissue, ...a stent. After stent deployment, ...

36

Original Article Angiotensin type 1 receptor A1166C gene polymorphism is associated with endothelial dysfunction and in-stent restenosis after percutaneous coronary intervention

Original Article Angiotensin type 1 receptor A1166C gene polymorphism is associated with endothelial dysfunction and in-stent restenosis after percutaneous coronary intervention

... in-stent restenosis (ISR) associated with altered endothelial functions has limited the clinical application of it; preventive medication with aspirin and statins has underlying adverse effects despite ...

8

Transcranial doppler sonography is not a valid diagnostic tool for detection of basilar artery stenosis or in-stent restenosis: a retrospective diagnostic study

Transcranial doppler sonography is not a valid diagnostic tool for detection of basilar artery stenosis or in-stent restenosis: a retrospective diagnostic study

... small stent lumina have crit- ical limitations in detecting the true lumen within the ...the stent material ...in stent stenosis in the carotid artery ...in-stent restenosis for follow ...

6

Comparison of new-generation drug-eluting stents versus drug-coated balloon for in-stent restenosis: a meta-analysis of randomised controlled trials

Comparison of new-generation drug-eluting stents versus drug-coated balloon for in-stent restenosis: a meta-analysis of randomised controlled trials

... artery rEstenosis (SEDUCE) trial and Germany and Latvia in BIOLUX (Clinical perfor- mance of the Pantera Lux paclitaxel coated balloon ...hybrid stent system in patients with in-stent ...

11

Multidetector computed tomography angiography for assessment of in-stent restenosis: meta-analysis of diagnostic performance

Multidetector computed tomography angiography for assessment of in-stent restenosis: meta-analysis of diagnostic performance

... months, restenosis, defined as luminal narrowing of 50 percent or more occurred in no patient with a sirolimus stent com- pared to 23 percent of those with standard ...meta-analysis, restenosis was ...

11

Lumivascular Optical Coherence Tomography&ndash;Guided Atherectomy in Recurrent Femoropopliteal Occlusive Diseases Associated with In-Stent Restenosis: Case-Series Report

<p>Lumivascular Optical Coherence Tomography&ndash;Guided Atherectomy in Recurrent Femoropopliteal Occlusive Diseases Associated with In-Stent Restenosis: Case-Series Report</p>

... Abstract: Lumivascular optical coherence tomography (OCT) is a novel adjunct in the fi eld of medicine. It offers clear real-time imaging of artery walls before and during endovascular intervention. This study reports our ...

5

Serum Levels of Advanced Glycation End Products Are Associated with In Stent Restenosis in Diabetic Patients

Serum Levels of Advanced Glycation End Products Are Associated with In Stent Restenosis in Diabetic Patients

... The present study has some limitations, largely in the fact that the AGE serum levels were mea- sured only once, just before PCI. A serial follow- up of AGE levels can provide more accurate information. However, smooth ...

8

Plaque morphology detected with Duplex ultrasound before carotid angioplasty and stenting (CAS) is not a predictor of carotid artery in-stent restenosis, a case control study

Plaque morphology detected with Duplex ultrasound before carotid angioplasty and stenting (CAS) is not a predictor of carotid artery in-stent restenosis, a case control study

... Background: In-stent restenosis (ISR) is an important factor endangering the long-term safety and efficacy of carotid artery angioplasty and stenting (CAS). It is plausible that soft vulnerable plaques are ...

6

Comparison of Bare metal Vs Drug eluting stents for in-stent Restenosis among Diabetics

Comparison of Bare metal Vs Drug eluting stents for in-stent Restenosis among Diabetics

... (clinical restenosis), clinical angina symptoms and mortality at two years of follow-up were the primary end points of the ...angiographic restenosis, stent thrombosis, and the composite of death or ...

5

Diagnostic value of microRNA-143 in predicting in-stent restenosis for patients with lower extremity arterial occlusive disease

Diagnostic value of microRNA-143 in predicting in-stent restenosis for patients with lower extremity arterial occlusive disease

... implanted stent who refused to undergo a CTA review; (2) patients who did not take anti-platelet aggregation drugs; (3) patients who had ISR in two or more locations and received revascularization therapy within 1 ...

7

Carotid endarterectomy for treatment of carotid in-stent restenosis: long-term follow-up results and surgery experiences from one single centre

Carotid endarterectomy for treatment of carotid in-stent restenosis: long-term follow-up results and surgery experiences from one single centre

... the stent is long enough or placed in distal position out of the surgeon’s control, it will be difficult to operate, nerve dysfunction and dissection in the arterial distal position may ...long stent in the ...

7

Influence of Patient Age and Stenosis Location on Wingspan In Stent Restenosis

Influence of Patient Age and Stenosis Location on Wingspan In Stent Restenosis

... The primary limitations of the present study are that angio- graphic follow-up of all patients has not been completed at this time, and the absolute number of patients with follow-up is relatively small after they are ...

5

Time course analysis of gene expression identifies multiple genes with differential expression in patients with in-stent restenosis

Time course analysis of gene expression identifies multiple genes with differential expression in patients with in-stent restenosis

... clinical restenosis [2], which was defined by ischemic symptoms after stent implantation and evidence of flow limitation in the treated vessel by either invasive or non-invasive ...

11

Show all 932 documents...

Related subjects